At what serum paracetamol (acetaminophen) concentration and time after ingestion should N‑acetylcysteine be initiated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 27, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Paracetamol Level and NAC Initiation Threshold

N-acetylcysteine (NAC) should be initiated when the serum paracetamol concentration, drawn between 4 and 24 hours post-ingestion, plots at or above the "possible toxicity" treatment line on the Rumack-Matthew nomogram (150 mg/L at 4 hours or 50 mg/L at 12 hours). 1

Critical Timing for Serum Level Measurement

  • Draw the serum paracetamol level at 4 hours post-ingestion or as soon as possible thereafter if the patient presents within the 4-24 hour window 1, 2
  • Levels drawn before 4 hours are unreliable and must be repeated at 4 hours, as early concentrations cannot accurately predict hepatotoxicity risk 1, 3
  • The nomogram is only valid for levels drawn between 4 and 24 hours after a single acute ingestion 1

Common Pitfall: Pre-4-Hour Levels

Obtaining paracetamol concentrations before 4 hours occurs in 62% of early presentations but leads to inappropriate treatment decisions—patients are more likely to receive unnecessary NAC (29% vs 17%) and less likely to have properly timed levels obtained (59% vs 93% get a 4-hour level) 3. Never use pre-4-hour levels to guide NAC decisions.

The Rumack-Matthew Nomogram Treatment Thresholds

  • "Possible toxicity" treatment line: 150 mg/L (993 μmol/L) at 4 hours, declining to 50 mg/L at 12 hours 1, 4
  • High-risk threshold: Concentrations above 300 mg/L (1,985 μmol/L) at 4 hours indicate very high risk despite early treatment 5
  • Any level plotting at or above the treatment line mandates immediate NAC administration 1, 6

When to Start NAC Without Waiting for Levels

Start NAC immediately in these scenarios, without waiting for laboratory confirmation: 1

  • Unknown time of ingestion with any detectable paracetamol level 1
  • Delayed presentation >24 hours with suspected overdose (nomogram does not apply) 1
  • Any evidence of hepatotoxicity (AST/ALT >50 IU/L) with suspected paracetamol ingestion 1, 4
  • Established acute liver failure with suspected paracetamol etiology (AST/ALT >1,000 IU/L, elevated INR) 1, 6
  • Stated ingestion ≥10 g or 200 mg/kg (whichever is lower) in adults, even before levels return 1, 2

Special Scenarios Requiring Modified Thresholds

Repeated Supratherapeutic Ingestion (RSTI)

The nomogram does not apply to repeated ingestions. Treat with NAC if: 1, 2

  • ≥10 g or 200 mg/kg (whichever is less) in any single 24-hour period, OR
  • ≥6 g or 150 mg/kg (whichever is less) per 24-hour period for ≥48 hours, OR
  • Serum paracetamol ≥10 mg/mL at any time, OR
  • AST or ALT >50 IU/L with any detectable paracetamol

High-Risk Populations Requiring Lower Treatment Threshold

Treat with NAC even if levels fall below the standard treatment line in: 1, 4

  • Chronic alcohol users (severe hepatotoxicity documented with doses as low as 4-5 g/day) 1, 4
  • Malnourished or fasting patients (depleted glutathione stores) 4
  • Patients on enzyme-inducing drugs (anticonvulsants, rifampin) 6
  • Pre-existing liver disease (lower toxicity threshold) 4

For these patients, consider NAC if ingestion exceeds >4 g or 100 mg/kg per day 1, 2

Extended-Release Formulations

  • Obtain serial paracetamol levels at 4 hours and again 4-6 hours later (14 hours post-ingestion) 1, 4
  • Late increases in concentration can occur beyond 14 hours 4, 7
  • Start NAC if any level plots above the treatment line 1

Critical Time Windows and Hepatotoxicity Risk

The efficacy of NAC is time-dependent: 1

  • 0-8 hours: Only 2.9% develop severe hepatotoxicity when treated 1
  • 8-10 hours: 6.1% develop severe hepatotoxicity 1
  • 10-24 hours: 26.4% develop severe hepatotoxicity 1
  • >24 hours: Still beneficial (reduces mortality from 80% to 52% in fulminant hepatic failure) but significantly less effective 1, 6

All 11 deaths in the landmark Smilkstein cohort occurred in patients who received NAC more than 10 hours after ingestion 1, emphasizing the critical importance of the 8-10 hour window.

Algorithm for NAC Initiation

  1. Establish time of ingestion (if possible) 1, 2
  2. If <4 hours post-ingestion:
    • Do NOT draw paracetamol level yet 1, 3
    • Consider activated charcoal if <2 hours post-ingestion 2
    • Draw level at exactly 4 hours 1
  3. If 4-24 hours post-ingestion:
    • Draw stat paracetamol level immediately 1
    • Plot on Rumack-Matthew nomogram 1
    • Start NAC if at or above treatment line 1
  4. If >24 hours post-ingestion:
    • Nomogram does NOT apply 1
    • Draw paracetamol level AND liver function tests (AST, ALT, INR) 1
    • Start NAC immediately if: detectable paracetamol OR elevated transaminases OR suspected significant ingestion 1
  5. If unknown time:
    • Draw paracetamol level and LFTs immediately 1
    • Start NAC if any detectable paracetamol level 1

Key Caveats

  • Low or absent paracetamol levels do NOT rule out toxicity if ingestion was remote, occurred over several days, or timing is uncertain 1, 4
  • Patients may develop hepatotoxicity despite being stratified as "no risk" on the nomogram due to inaccurate history or increased susceptibility 1
  • Very high aminotransferases (AST/ALT >3,500 IU/L) are highly correlated with paracetamol poisoning and should prompt NAC treatment even without clear overdose history 1, 4
  • For combination products containing other medications, absorption kinetics may be altered—consider serial levels 7

References

Guideline

Acetaminophen Overdose Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Acetaminophen Toxicity Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

N-Acetylcysteine Administration in Acetaminophen Overdose

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.